A systematic review reveals that African children of 15–17 years demonstrate low hepatitis B vaccine seroprotection rates
Childhood HBV immunization remains globally fundamental to the elimination of hepatitis B
virus (HBV). However, monitoring proportions of HBV vaccine seroprotection and their …
virus (HBV). However, monitoring proportions of HBV vaccine seroprotection and their …
Beyond schistosomiasis: unraveling co-infections and altered immunity
DJ Perera, C Koger-Pease, K Paulini… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Schistosomiasis is a neglected tropical disease caused by the helminth Schistosoma spp.
and has the second highest global impact of all parasites. Schistosoma are transmitted …
and has the second highest global impact of all parasites. Schistosoma are transmitted …
The subdued post-boost spike-directed secondary igG antibody response in Ugandan recipients of the pfizer-bioNTech BNT162b2 vaccine has implications for local …
V Ankunda, JS Katende, GK Oluka, J Sembera… - Frontiers in …, 2024 - frontiersin.org
Introduction This study aimed to delineate longitudinal antibody responses to the Pfizer-
BioNTech BNT162b2 COVID-19 vaccine within the Ugandan subset of the Sub-Saharan …
BioNTech BNT162b2 COVID-19 vaccine within the Ugandan subset of the Sub-Saharan …
Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations
J Serwanga, V Ankunda, JS Katende, C Baine… - Frontiers in …, 2024 - frontiersin.org
Introduction This study sought to elucidate the long-term antibody responses to the Moderna
mRNA-1273 COVID-19 vaccine within a Ugandan cohort, aiming to contribute to the sparse …
mRNA-1273 COVID-19 vaccine within a Ugandan cohort, aiming to contribute to the sparse …
The single-dose Janssen Ad26. COV2. S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort
J Serwanga, L Kato, GK Oluka, V Ankunda… - Frontiers in …, 2024 - frontiersin.org
Introduction The study investigation examined the immune response to the Janssen Ad26.
COV2. S COVID-19 vaccine within a Ugandan cohort, specifically targeting antibodies …
COV2. S COVID-19 vaccine within a Ugandan cohort, specifically targeting antibodies …
IL‐21‐IgFc immunotherapy alters transcriptional landscape of lymph node cells leading to enhanced flu vaccine response in aging and SIV infection
Aging people living with HIV (PWH) frequently manifest impaired antibody (Ab) responses to
seasonal flu vaccination which has been attributed to ongoing inflammation and immune …
seasonal flu vaccination which has been attributed to ongoing inflammation and immune …
Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied …
J Serwanga, GK Oluka, C Baine, V Ankunda… - Plos one, 2024 - journals.plos.org
Understanding SARS-CoV-2 vaccine-induced antibody responses in varied antigenic and
serological prior exposures can guide optimal vaccination strategies for enhanced …
serological prior exposures can guide optimal vaccination strategies for enhanced …
Schistosome Transgenesis: The Long Road to Success
BH Kalinna, AG Ross, AK Walduck - Biology, 2024 - mdpi.com
Simple Summary The neglected tropical disease schistosomiasis is a worm infection that is
caused by parasitic blood flukes. The disease is found in sub-Saharan Africa, the Middle …
caused by parasitic blood flukes. The disease is found in sub-Saharan Africa, the Middle …
[PDF][PDF] Violet Ankunda1, Joseph Ssebwana Katende1, 2, Gerald Kevin Oluka1, 2, Jackson Sembera1, Claire Baine1, Geoffrey Odoch2, Peter Ejou2, Laban Kato2, and …
AJ Auguste, A Vijayan, JT Gordy, J Serwanga - 2024 - scienceopen.com
Methods: We enrolled 48 participants and collected 320 specimens over 12 months after the
primary vaccination dose. A validated enzyme-linked immunosorbent assay (ELISA) was …
primary vaccination dose. A validated enzyme-linked immunosorbent assay (ELISA) was …
The Distinct Absence of a Post-boost Spike-IgG Antibody Surge in Ugandan Recipients of the Pfizer-BioNTech Vaccine Has Implications for Vaccination Policies
J Serwanga, V Ankunda, JS Katende, J Sembera… - 2023 - preprints.org
This study aimed to delineate the longitudinal antibody responses to the Pfizer-BioNTech
COVID-19 vaccine (BNT162b2) within the Ugandan subset of the Sub-Saharan African …
COVID-19 vaccine (BNT162b2) within the Ugandan subset of the Sub-Saharan African …